Wafaa Rashed

Dr. Wafaa Rashed

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2020 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
PDF file
WRWafaa Rashed
Wafaa Rashed
MKMohamed Ahmed Mohamed Kandeil
Mohamed Ahmed Mohamed Kandeil
MMMohamed Mahmoud
Mohamed Mahmoud
SESameera Ezzat
Sameera Ezzat
Background: Worldwide, hepatocellular carcinoma (HCC) is a universal problem and its epidemiological data showed variation from place to place. Hepatocellular carcinoma (HCC) is the sixth and fourth common cancer in worldwide and Egypt, respectively. Egypt ranks the third and 15th most populous country in Africa and worldwide, respectively. The aim of this review is to compare the status of HCC in Egypt to that in the worldwide from different issues; risk factors, screening and surveillance, diagnosis and treatment, prevention, as well as research strategy. Main body: The risk factors for HCC in Egypt are of great importance to be reported. The risk factor for HCC are either environmental- or host/genetic-related risk factors. In the last years, there is a tangible improvement of both screening and surveillance strategies of HCC in Egypt. The unprecedented national screening campaign launched by the end of 2018 is a mirror image of this improvement. While the improvement of the HCC prevention requires the governmental health administration to implement health policies. Although the diagnosis of Egyptian HCC patients follows the international guidelines but HCC treatment options are limited in terms of cost. In addition, there are limited Egyptian reports about HCC survival and relapse. Both basic and clinical HCC research in Egypt are still limited compared to worldwide. Short conclusion: Deep analysis and understanding of factors affecting HCC burden variation worldwide help in customization of efforts exerted to face HCC in different countries especially large country like Egypt. Overall, the presence of a research strategy to fight HCC in Egyptian patients will help in the optimum allocation of available resources to reduce the numbers of HCC cases and deaths and to improve the quality of life.

11 September 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
OOOlayinka O. Ogunleye
Olayinka O. Ogunleye
DBDebashis Basu
Debashis Basu
DMDebjani Mueller
Debjani Mueller
JSJacqueline Sneddon
Jacqueline Sneddon
RSR. Andrew Seaton
R. Andrew Seaton
BGBrian Godman
Brian Godman
Background: The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. Objective: Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. Our Approach: Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. Ongoing Activities: Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. Conclusion: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.

1 April 2016 in The Lancet Haematology
Verified
Journal Article
Closed access
EMErin L Marcotte
Erin L Marcotte
TTThomas P Thomopoulos
Thomas P Thomopoulos
CIClaire Infante-Rivard
Claire Infante-Rivard
JCJacqueline Clavel
Jacqueline Clavel
EPEleni Th Petridou
Eleni Th Petridou
LSLogan Garrett Spector
Logan Garrett Spector

1 November 2014 in Epidemiology
Verified
Journal Article
Closed access
CMCatherine Metayer
Catherine Metayer
EMElizabeth Milne
Elizabeth Milne
JDJohn D. Dockerty
John D. Dockerty
JCJacqueline Clavel
Jacqueline Clavel
MPMaria S. Pombo-De-Oliveira
Maria S. Pombo-De-Oliveira
CIClaire Infante-Rivard
Claire Infante-Rivard
Background: Maternal prenatal supplementation with folic acid and other vitamins has been inconsistently associated with a reduced risk of childhood acute lymphoblastic leukemia (ALL). Little is known regarding the association with acute myeloid leukemia (AML), a rarer subtype. Methods: We obtained original data on prenatal use of folic acid and vitamins from 12 case-control studies participating in the Childhood Leukemia International Consortium (enrollment period: 1980–2012), including 6,963 cases of ALL, 585 cases of AML, and 11,635 controls. Logistic regression was used to estimate pooled odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for child’s age, sex, ethnicity, parental education, and study center. Results: Maternal supplements taken any time before conception or during pregnancy were associated with a reduced risk of childhood ALL; odds ratios were 0.85 (95% CI = 0.78–0.92) for vitamin use and 0.80 (0.71–0.89) for folic acid use. The reduced risk was more pronounced in children whose parents’ education was below the highest category. The analyses for AML led to somewhat unstable estimates; ORs were 0.92 (0.75–1.14) and 0.68 (0.48–0.96) for prenatal vitamins and folic acid, respectively. There was no strong evidence that risks of either types of leukemia varied by period of supplementation (preconception, pregnancy, or trimester). Conclusions: Our results, based on the largest number of childhood leukemia cases to date, suggest that maternal prenatal use of vitamins and folic acid reduces the risk of both ALL and AML and that the observed association with ALL varied by parental education, a surrogate for lifestyle and sociodemographic characteristics.

4 December 2019 in Cancer and Metastasis Reviews
Verified
Journal Article
Closed access
PDF file
WRWafaa Rashed
Wafaa Rashed
EMEslam Maher
Eslam Maher
MAMohamed Adel
Mohamed Adel
OSOssama Saber
Ossama Saber
MZMohamed Saad Zaghloul
Mohamed Saad Zaghloul

14 May 2018 in European Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
EPEleni Th. Petridou
Eleni Th. Petridou
MGMarios K. Georgakis
Marios K. Georgakis
FEFriederike Erdmann
Friederike Erdmann
XMXiaomei Ma
Xiaomei Ma
JHJulia E. Heck
Julia E. Heck
ASAlkistis Skalkidou
Alkistis Skalkidou